Meet the Team: Shernan Holtan, MD - Takeaways - MDSpire

Meet the Team: Shernan Holtan, MD

The newest member of the cellular therapy research team and Chief of the Bone Marrow and Transplantation Service at Roswell Park Comprehensive Cancer Center is eager to continue advancing the field.

  • February 23, 2024

Share

  • 1

    Shernan Holtan, MD, is the Chief of the Bone Marrow and Transplantation Service at Roswell Park Comprehensive Cancer Center.

  • 2

    Holtan's research focuses on preventing graft versus host disease and improving patient care and quality of life during treatment.

  • 3

    She has developed clinical trials that significantly reduced the incidence of graft versus host disease from 50% to 5-10%.

  • 4

    Holtan aims to streamline treatment by reducing medication burdens and enhancing supportive care, including nutrition and exercise.

  • 5

    The team at Roswell Park is committed to transforming therapies and improving patient outcomes in the field of cellular therapy.

Original Source(s)

Meet the Team: Shernan Holtan, MD

  • February 23, 2024

Related Content

Granulocyte transfusions in haematopoietic cell transplants and leukaemia: the phoenix or beating a dead horse?

Warning Signs of Hematologic Malignancies in the Primary Care Setting

Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat cancers as early as possible.

  • March 22, 2021

  • 1 min
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020